AAAAAA

   
Results: 1-7 |
Results: 7
Risedronate: A new oral bisphosphonate
Authors: Umland, EM Boyce, EG
Citation: Em. Umland et Eg. Boyce, Risedronate: A new oral bisphosphonate, CLIN THER, 23(9), 2001, pp. 1409-1421
Sildenafil citrate: A therapeutic update
Authors: Boyce, EG Umland, EM
Citation: Eg. Boyce et Em. Umland, Sildenafil citrate: A therapeutic update, CLIN THER, 23(1), 2001, pp. 2-23
Nonsteroidal anti-inflammatory drugs: Review of factors guiding formulary selection
Authors: Boyce, EG Takiya, L
Citation: Eg. Boyce et L. Takiya, Nonsteroidal anti-inflammatory drugs: Review of factors guiding formulary selection, FORMULARY, 35(2), 2000, pp. 142
Celecoxib: A COX-2 inhibitor for the treatment of osteoarthritis and rheumatoid arthritis
Authors: Boyce, EG Breen, GA
Citation: Eg. Boyce et Ga. Breen, Celecoxib: A COX-2 inhibitor for the treatment of osteoarthritis and rheumatoid arthritis, FORMULARY, 34(5), 1999, pp. 405
The impact of estrogen replacement therapy and raloxifene on osteoporosis,cardiovascular disease, and gynecologic cancers
Authors: Umland, EM Rinaldi, C Parks, SM Boyce, EG
Citation: Em. Umland et al., The impact of estrogen replacement therapy and raloxifene on osteoporosis,cardiovascular disease, and gynecologic cancers, ANN PHARMAC, 33(12), 1999, pp. 1315-1328
Potential risk factors associated with thrombocytopenia in a surgical intensive care unit
Authors: Cawley, MJ Wittbrodt, ET Boyce, EG Skaar, DJ
Citation: Mj. Cawley et al., Potential risk factors associated with thrombocytopenia in a surgical intensive care unit, PHARMACOTHE, 19(1), 1999, pp. 108-113
Predictive performance of ten equations for estimating creatinine clearance in cardiac patients
Authors: Spinler, SA Nawarskas, JJ Boyce, EG Connors, TE Charland, SL Goldfarb, S
Citation: Sa. Spinler et al., Predictive performance of ten equations for estimating creatinine clearance in cardiac patients, ANN PHARMAC, 32(12), 1998, pp. 1275-1283
Risultati: 1-7 |